August 1, 2019
The Lupus Research Alliance (LRA), the largest private funder of lupus research in the world, is very pleased to announce a unique new partnership with Celgene Corporation that provides $3,000,000 for bold cutting-edge research projects. This opportunity will focus on understanding the underlying mechanisms of disease, addressing lupus heterogeneity — how much the disease varies from person to person — and identifying novel biomarkers.
This collaboration brings together two leaders in harnessing the power of science to improve lives. The LRA, a worldwide leader in the funding of lupus research, is driving the most important scientific discoveries in the field. As a global biopharmaceutical company, Celgene is equally committed to developing and delivering life-changing treatments for people with lupus.
More details are to come, but meanwhile we wanted to share our excitement over this major alliance that takes a giant step forward for lupus research.
